4 lakh staff will go without pay, 3.8 lakh ‘on leave’ as US shutdown begins

Agencies
December 23, 2018

Washington, Dec 23: The US government was partially shut down early on Saturday in a fierce dispute over President Donald Trump’s demands that Congress assign USD 5 billion for a wall along the border with Mexico.

After failing to strike a budget deal on Friday, congressional leaders and the White Housepledged to keep talking through the weekend in search of a deal to end the shutdown ahead of the Christmas holiday.

The impasse came after Trump threw a wrench into the works earlier in the week by refusing to agree to a short-term funding deal cut by Democratic and Republican senators because it did not include the USD 5 billion for his border wall.

The US House of Representatives, where Republicans have a majority until Democrats take over on January 3, then passed a bill that including the $5 billion, but it ran aground in the Senate and the shutdown began at midnight on Friday.

After it became clear the House bill lacked the votes to pass, Senate leaders huddled with vice president Mike Pence and other White House officials to try to figure out a path forward.

They failed and lawmakers in both houses of Congress were sent home.

Trump tried to blame Democrats.

“We’re going to have a shutdown. There’s nothing we can do about that because we need the Democrats to give us their votes,” he said in a video posted to his Twitter account two hours before the midnight deadline.

Democrats repeatedly reminded Trump, and voters, that he said last week he would be “proud” to shut the government down in order to get wall funding.

“President Trump has thrown a temper tantrum and now has us careening towards a ‘Trump shutdown’ over Christmas,” Senate Democratic leader Chuck Schumer said on the Senate floor on Friday.

About three-quarters of federal government programs are funded through to Sept 30 next year, but the financing for all others - including the departments of Homeland Security, Justice and Agriculture - expired at midnight.

Federal parks will close and more than 400,000 federal “essential” employees in those agencies will work without pay until the dispute is resolved. Another 380,000 will be “furloughed”, meaning they are put on temporary leave.

Law enforcement efforts, border patrols, mail delivery and airport operations will keep running.

Impasse

For the shutdown to end, both the House and the Senate will have to approve any deal negotiated between Trump’s team and Republican and Democratic leaders.

The shutdown could persist at least until a new Congress convenes on January 3, and Democrats take control of the House from Republicans. That does not necessarily mean, however, that Trump would agree to a compromise.

The shutdown comes at the end of a perilous week for the president, one that saw Defense Secretary James Mattis resign in protest after Trump’s sudden decision to pull US troops out of Syria.

The Syria move was widely criticized, even by senior Republicans in Congress. And continued heavy losses in the stock market were in part fueled by the political turmoil.

While Trump made the promise of building a border wall a fixture of his 2016 election campaign, it is not a top-tier priority for most Americans.

According to a Reuters/Ipsos poll in late November, only 31 percent of those surveyed said improved border security should be one of the top three priorities for Congress.

That suggests Trump is taking a political risk by gambling on a shutdown to press his point at a time when Democrats are gearing up for their 2020 presidential primary and looking for issues with which to seize an advantage.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 11,2020

New York, Jan 11: The United Nations Security Council (UNSC) on Friday renewed a six-year-long cross-border humanitarian aid deliveries mechanism into Syria.

According to Sputnik, the Security Council voted in favour of a resolution on Friday that allows cross border deliveries to be conducted via Turkey, preserving two checkpoints and excluding the Al-Yarubiyah border crossing with Iraq and the Al-Ramtha crossing with Jordan, until July 10, 2020.

Russia proposed to amend the adopted resolution by replacing a part of the draft which stipulates that humanitarian assistance into Syria should be delivered based on the principles of humanity, neutrality, impartiality and independence by the phrase that such aid should be provided "in accordance with the guiding principles of humanitarian emergency assistance, as contained in UNGA resolution 46/182."

The agreement was reached after Belgium and Germany decided to amend the original version of their joint resolution, which proposed keeping three points for cross-border deliveries into the Arab republic.

In December last year, the United Nations had said that over 235,000 people fled the Idlib region in the last two weeks after Russia and Syria launched airstrikes in a bid to take over the last major opposition bastion.

Russia backed Syria government launched a fresh assault to capture the province.

Syrian Bashar al-Assad regime, backed by Iran, has reportedly promised to take back the rebel-controlled area and broke a ceasefire that was announced in August.

They have since December 19 seized dozens of towns and villages from armed fighters amid clashes that have killed hundreds on both sides.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 1,2020

Washington, Jul 1: The United States has approved four coronavirus vaccine candidates for clinical trials, Food and Drug Administration (FDA) head Stephen Hahn told reporters.

"Four vaccines have been approved for moving into clinical trials... and another six are in the pipeline for us to review," Hahn said during a press briefing on Tuesday.

The US Administration launched in May Operation Warp Speed, a joint project of Health and Defense Departments, which aims to deliver 300 million doses of a vaccine for COVID-19 by January 2021.

The country's top pandemics expert Anthony Fauci warned on Tuesday, however, that there is no certainty the United States will be able to develop a vaccine against COVID-19 that works and will be safe.

Data on vaccine effectiveness, he added, may be available in the winter or early next year.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.